
Moderna’s $2.25 Billion Settlement with Arbutus: Redefining the IP Value of mRNA Delivery
The landmark settlement between Moderna and Arbutus Biopharma over LNP delivery technology marks a historic turning point for the biotech industry, establishing the highest valuation yet for mRNA platform IP.









































